international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
Press Release: Ninth International Pharma Compliance Congress Features a Global Transparency Panel
    international pharmaceutical compliance congress
  • A Hybrid Conference and Internet Event
  • Sponsored by ethics, the International Society of Healthcare Compliance Professionals
  • Co-sponsored by the Pharmaceutical Compliance Forum
  • May 11 - 13, 2015
  • Onsite at the Crowne Plaza Brussels - Le Palace in Brussels, Belgium
  • In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
  • www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com

FEATURING A GLOBAL TRANSPARENCY PANEL BY

Holger Diener, PhD
Managing Director, Association of Voluntary, Self-Regulation for the Pharmaceutical Industry, Berlin, Germany

George Fife
Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Former, Compliance & Internal Audit Leader, EMEA, GE Healthcare, Paris, France

Dr. Gudula Petersen
Chief Compliance Officer Europe & Australia, Grunenthal, Aachen, Germany

Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain

Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Co-chair, EFPIA Compliance Workgroup, Munich, Germany, (Moderator)

WASHINGTON DC USA -- CME UPDATE NEWS SERVICE™ -- JANUARY 13, 2015: The Ninth International Pharmaceutical Compliance Congress, www.InternationalPharmaCongress.com, will take place on May 11 - 13, 2015 at the Crowne Plaza Brussels - Le Palace in Brussels, Belgium. Registrants may attend the event in person or online (live webcast and archived for 6 months).



KEYNOTE SPEAKERS

Robert Barrington, PhD
Executive Director, Transparency International-UK, London, UK

Richard Bergström
Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Former Director General, LIF Sweden, Brussels, Belgium

FEATURING AN EFPIA STAKEHOLDER WORKSHOP
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is offering an independent EFPIA STAKEHOLDER WORKSHOP on Monday, May 11, 2014.

FEATURED FACULTY

Ted Acosta, Esq.
Principal, Fraud Investigation & Dispute Services, EY, Former Senior Counsel, Office of Inspector General, United States Department of Health and Human Services, New York, NY, USA and Paris, France

Andy Bender
President and Founder, Polaris, New York, NY, USA


Flavia Bollinger
Head Integrity and Compliance MENA (Middle East, North Africa), Novartis Pharma Services AG, Dubai, UAE

Fiona Carlin, LLB
Managing Partner, European & Competition Law Practice, Baker & McKenzie, Brussels, Belgium

Holger Diener, PhD
Managing Director, Association of Voluntary, Self-Regulation for the Pharmaceutical Industry, Berlin, Germany

Kip Ebel, MBA
Principal, Ernst & Young, New York, NY

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

George Fife
Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Former, Compliance & Internal Audit Leader, EMEA, GE Healthcare, Paris, France



Martin Fürle
Vice President, General Counsel & Chief Compliance Officer, DAIICHI SANKYO EUROPE GmbH, Munich, Germany

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY

Ulf H. Grundmann, JD
Partner, Life Science Practice Group, King and Spalding, Frankfurt, Germany

Thomas K. Hauser, LLM
Chief Compliance Officer, Siemens Healthcare, Nürnberg, Germany

Erinn Hutchinson
Partner, Advisory Services, PricewaterhouseCoopers, Philadelphia, PA

Isaure Kergall-Gayet, DEA-Law
Compliance & Business Integrity Director France, Sanofi, Former VP, Chief Ethics & Compliance Officer, Ipsen, Former, Director, Ethics & Compliance Officer, Lilly France, Paris, France

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC

Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC, USA

Aline Lautenberg
General Counsel - Director Legal & Compliance, Eucomed, EDMA and MedTech Europe, Brussels, Belgium

Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA

Dr. Gudula Petersen
Chief Compliance Officer Europe & Australia, Grunenthal, Aachen, Germany

Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD, USA

Christine Sainvil
Compliance Officer, EthicalMedTech, Brussels, Belgium

Brian Sharkey, Esq.
Counsel, Porzio, Bromberg & Newman, Director of Compliance and Legal Affairs, Porzio Governmental Affairs, LLC, Morristown, NJ, USA

Heather Simmonds
Director, Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK

Melda Tanyeri, MS, MBA
Director, Fraud Investigation & Dispute Services, Ernst & Young, London, UK

Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA

Dumitru Uta, MD, MBA, CCEP
Ethics and Compliance Director, South-East Europe, Eli Lilly and Company, Bucharest, Romania

Frank Wartenberg, PhD
President, Central Europe, IMS Health, Frankfurt/Main, Germany

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland

Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium

Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain

OTHER INTERNATIONAL PHARMA CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin

2011 - Istanbul


2011 - Singapore


2012 - Budapest


2012 - Shanghai

2012 - São Paulo


2013 - Madrid


2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City





SPEAKER PRESENTATION PROPOSALS
Speaker/Presentation Proposals for the International Pharma Congress May Be Submitted Through Our Online Form
- Click Here -
SPONSORED BY:



CO-SPONSORED BY:



CONGRESS CO CHAIRS

Ann Beasley
Chief Compliance Officer, Biogen Idec International, GmbH, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Cambridge, MA, USA

Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Co-chair, EFPIA Compliance Workgroup, Munich, Germany

Dominique Laymand, Esq.
President, International Society of Healthcare Ethics, and Compliance Professionals (ETHICS), Executive Director Compliance & Ethics EMEA, (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France

Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Board Member, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
GRANTORS:
BRONZE














FOLLOW INTERNATIONAL PHARMA CONGRESS ON




INTERNATIONAL PHARMA CONGRESS IS
PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction


LIVE AND ARCHIVED WEBCAST PARTICIPATION
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office





WEBCAST INTERFACE SAMPLE

Click here for a sample stream




This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.





CONGRESS REGISTRATION

For Congress registration information, visit www.InternationalPharmaCongress.com/registration.php, email registration@hcconferences.com, or call 800-503-8171.


CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information, visit www.internationalpharmacongress.com/promotional/index.html, or contact Justin Sorensen, Exhibit Manager, at 206-452-0609 phone, 206-319-5303 fax, or exhibits@hcconferences.com.